Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- Switching from a boosted PI plus 2 NRTIs to emtricitabine/rilpivirine/tenofovir DF has been associated with improved lipid parameters[Palella 2014]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content